Experienced Leadership

Helix is led by experienced Management and Board team with excellent pharmaceutical development expertise and proven business skills. The group is committed in developing novel medicines through DOS47 and cell-based platforms.

MANAGEMENT BOARD

Sven Rohmann

CEO
MD, PhD, MBA

Experienced biotech entrepreneur, pharma manager (Merck, Novartis) and life science venture capitalist in the field of oncology (Burrill & Company, Adiuvo Investments)

Patrick Frankham

COO
PhD, MBA

Biotech and pharma oncology drug development experience with past senior roles at Boehringer Ingelheim, ICON Clinical and AeternaZentaris

Heman Chao

CSO
PhD

Biochemist with expertise in protein drug development. Previous role with Sensium Technologies Inc.

Steve Demas

CMO
Bsc

Clinical operations experience with past roles at BioMS Medical, Bayer and Sanofi Synthelabo

Frank Michalargias

CFO
CPA, CA

Public company CFO with broad industry experience including senior positions with Unilever and Huhtamaki Oy

Paweł Wiśniewski

CEO Poland
PhD

Biochemistry background;  co-founder Institute of Genetic Analysis

BOARD OF DIRECTORS

Sven Rohmann

MD, PhD, MBA

Experienced biotech entrepreneur, pharma manager (Merck, Novartis) and life science venture capitalist in the field of oncology (Burrill & Company, Adiuvo Investments)

Albert Beraldo

B.Comm, CA

Founder/CEO of Alveda Pharmaceuticals, recently sold to Teligent Inc (NASDAQ), Former CEO of Bioniche Pharma Group Ltd.

Marek Orłowski

MD

Chairman/Founder Adiuvo Investments, Founder Nepentes, sold to Sanofi Aventis

Sławomir Majewski

MD, PhD

Vice Rector of the Medical University of Warsaw, Corresponding Member of the Polish Academy of Science

Sylwester Cacek

Founder of Dominet Bank which was sold to Fortis Bank Group; President/founder of Sfinks Polska

George Anders

Prof., PhD

Engineering professor, University of Toronto, Technical University of Lodz

Ted
Witek

PhD, MBA

Retired President, CEO Boehringer-Ingelheim Canada Ltd.; Senior Vice President, Corporate Partnerships and Chief Scientific Officer of Innoviva Inc.